Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity

References

• Hardoon SL Morris RW Thomas MC Wannamethee SG Lennon LT Whincup PH Is the recent rise in type 2 diabetes incidence from 1984 to 2007 explained by the trend in increasing BMI?: evidence from a prospective study of British men Diabetes Care 2010 33 7 1494 1496 20413526
   PubMed Web of Science ®Google Scholar
• Sarwar N Gao P Seshasai SR Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Lancet 2010 375 9733 2215 2222 20609967
   PubMed Web of Science ®Google Scholar
• Viollet B Guigas B Sanz Garcia N Leclerc J Foretz M Andreelli F Cellular and molecular mechanisms of metformin: an overview Clin Sci (Lond) 2012 122 6 253 270 22117616
   PubMed Web of Science ®Google Scholar
• Fryer LG Parbu-Patel A Carling D The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J Biol Chem 2002 277 28 25226 25232 11994296
   PubMed Web of Science ®Google Scholar
• Hawley SA Ross FA Chevtzoff C Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation Cell Metab 2010 11 6 554 565 20519126
   PubMed Web of Science ®Google Scholar
• Zhang Y Wang Y Bao C Metformin interacts with AMPK through binding to gamma subunit Mol Cell Biochem 2012 368 1–2 69 76 22644486
   PubMed Web of Science ®Google Scholar
• Grisouard J Timper K Radimerski TM Mechanisms of metformin action on glucose transport and metabolism in human adipocytes Biochem Pharmacol 2010 80 11 1736 1745 20816671
   PubMed Web of Science ®Google Scholar
• Garber AJ Duncan TG Goodman AM Mills DJ Rohlf JL Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial Am J Med 1997 103 6 491 497 9428832
   PubMed Web of Science ®Google Scholar
• Proctor WR Bourdet DL Thakker DR Mechanisms underlying saturable intestinal absorption of metformin Drug Metab Dispos 2008 36 8 1650 1658 18458049
   PubMed Web of Science ®Google Scholar
• Okayasu S Kitaichi K Hori A The evaluation of risk factors associated with adverse drug reactions by metformin in type 2 diabetes mellitus Biol Pharm Bull 2012 35 6 933 937 22687486
   PubMed Web of Science ®Google Scholar
• Hardie DG Pan DA Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase Biochem Soc Trans 2002 30 Pt 6 1064 1070 12440973
   PubMed Web of Science ®Google Scholar
• Srivastava RA Pinkosky SL Filippov S Hanselman JC Cramer CT Newton RS AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases J Lipid Res 2012 53 12 2490 2514 22798688
   PubMed Web of Science ®Google Scholar
• Suter M Riek U Tuerk R Schlattner U Wallimann T Neumann D Dissecting the role of 5′-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase J Biol Chem 2006 281 43 32207 32216 16943194
   PubMed Web of Science ®Google Scholar
• Salminen A Hyttinen JM Kaarniranta K AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan J Mol Med (Berl) 2011 89 7 667 676 21431325
   PubMed Web of Science ®Google Scholar
• Lan F Cacicedo JM Ruderman N Ido Y SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation J Biol Chem 2008 283 41 27628 27635 18687677
   PubMed Web of Science ®Google Scholar
• Canto C Auwerx J PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure Curr Opin Lipidol 2009 20 2 98 105 19276888
   PubMed Web of Science ®Google Scholar
• Bruckbauer A Zemel MB Thorpe T Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice Nutr Metab (Lond) 2012 9 1 77 22913271
   PubMed Web of Science ®Google Scholar
• Feige JN Lagouge M Canto C Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab 2008 8 5 347 358 19046567
   PubMed Web of Science ®Google Scholar
• Nin V Escande C Chini CC Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase J Biol Chem 2012 287 28 23489 23501 22553202
   PubMed Web of Science ®Google Scholar
• Souza-Mello V Gregorio BM Cardoso-de-Lemos FS de Carvalho L Aguila MB Mandarim-de-Lacerda CA Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet Clin Sci (Lond) 2010 119 6 239 250 20415664
   PubMed Web of Science ®Google Scholar
• Okamoto T Kanemoto N Ohbuchi Y Okano M Fukui H Sudo T Characterization of STZ-induced type 2 diabetes in Zucker fatty rats Exp Anim 2008 57 4 335 345 18633156
   PubMed Web of Science ®Google Scholar
• Grace MH Ribnicky DM Kuhn P Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, Vaccinium angustifolium Aiton Phytomedicine 2009 16 5 406 415 19303751
   PubMed Web of Science ®Google Scholar
• Hou M Venier N Sugar L Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet Biochem Biophys Res Commun 2010 397 3 537 542 20573602
   PubMed Web of Science ®Google Scholar
• Caton PW Nayuni NK Kieswich J Khan NQ Yaqoob MM Corder R Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5 J Endocrinol 2010 205 1 97 106 20093281
   PubMed Web of Science ®Google Scholar
• Caton PW Kieswich J Yaqoob MM Holness MJ Sugden MC Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice Diabetes Obes Metab 2011 13 12 1097 1104 21733059
   PubMed Web of Science ®Google Scholar
• Hawley SA Gadalla AE Olsen GS Hardie DG The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism Diabetes 2002 51 8 2420 2425 12145153
   PubMed Web of Science ®Google Scholar
• Owen MR Doran E Halestrap AP Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem J 2000 348 Pt 3 607 614 10839993
   PubMed Web of Science ®Google Scholar
• Ouyang J Parakhia RA Ochs RS Metformin activates AMP kinase through inhibition of AMP deaminase J Biol Chem 2011 286 1 1 11 21059655
   PubMed Web of Science ®Google Scholar
• Park SJ Ahmad F Philp A Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 2012 148 3 421 433 22304913
   PubMed Web of Science ®Google Scholar
• Price NL Gomes AP Ling AJ SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab 2012 15 5 675 690 22560220
   PubMed Web of Science ®Google Scholar
• Bruckbauer A Zemel MB Effects of dairy consumption on SIRT1 and mitochondrial biogenesis in adipocytes and muscle cells Nutr Metab (Lond) 2011 8 91 22185590
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F Pathogenesis and glycemic management of type 2 diabetes mellitus: a physiological approach Arch Iran Med 2012 15 4 239 246 22424044
   PubMed Web of Science ®Google Scholar
• Petersen KF Shulman GI Etiology of insulin resistance Am J Med 2006 119 5 Suppl 1 S10 S16 16563942
   PubMed Web of Science ®Google Scholar
• Morino K Petersen KF Dufour S Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents J Clin Invest 2005 115 12 3587 3593 16284649
   PubMed Web of Science ®Google Scholar
• Petersen KF Befroy D Dufour S Mitochondrial dysfunction in the elderly: possible role in insulin resistance Science 2003 300 5622 1140 1142 12750520
   PubMed Web of Science ®Google Scholar
• Gauthier MS O’Brien EL Bigornia S Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans Biochem Biophys Res Commun 2011 404 1 382 387 21130749
   PubMed Web of Science ®Google Scholar
• Fujii N Ho RC Manabe Y Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice Diabetes 2008 57 11 2958 2966 18728234
   PubMed Web of Science ®Google Scholar
• Bergeron R Previs SF Cline GW Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats Diabetes 2001 50 5 1076 1082 11334411
   PubMed Web of Science ®Google Scholar
• Pold R Jensen LS Jessen N Long-term AICAR administration and exercise prevents diabetes in ZDF rats Diabetes 2005 54 4 928 934 15793229
   PubMed Web of Science ®Google Scholar
• Cool B Zinker B Chiou W Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Cell Metab 2006 3 6 403 416 16753576
   PubMed Web of Science ®Google Scholar